Yet Another FDA-Approved Drug Linked To Alzheimer’s

Paige Leskin, July 7, 2019

Business Insider – Prostate cancer patients who take a hormone-suppressing drug may be at an increased risk for dementia and Alzheimer’s, a study has found.

The study of more than 150,000 men found a link between the degenerative diseases and a treatment drug called androgen deprivation therapy.

Researchers cautioned doctors to further consider the risks of ADT before giving it to their patients to treat prostate cancer.

There’s a 20-percent higher chance of having dementia for older men who have taken the prostate cancer treatment, according to the research study from JAMA Network … Doctor Manages Prostate Cancer Without Surgery

“Our results suggest that clinicians need to carefully weigh the long-term risks and benefits of exposure to ADT in patients with a prolonged life expectancy and stratify patients based on dementia risk prior to ADT initiation,” the researchers wrote in their study … Read more. 

RECENTLY: 

The Hair Transplant Industry Could Be Doomed After This 

Doctor: Very Common Sleep Disorder Hastens Alzheimer’s

Neck Sign Shows Alzheimer’s Ten Years In Advance

Is Alzheimer’s An Infection?